Abstract P1-07-14: Real-life analysis evaluating >1000 N0/N1mi estrogen receptor (ER)+ breast cancer patients for whom treatment decisions incorporated the 21-gene recurrence score (RS) result: Clinical outcomes with median follow up of > 9 yearsSalomon M. Stemmer, N Ben Baruch, M. Steiner et al.|Cancer Research|2018Cited by 0